ArticleBJR case reports2023
Surveillance imaging of type II endoleak with contrast-enhanced ultrasound.
Article in BJR case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Microvascular blood flow ultrasound imaging with microbubble-based H-Scan technology.Medical & biological engineering & computing · 2025Article
- Implantable Pressure-Sensing Devices for Monitoring Abdominal Aortic Aneurysms in Post-Endovascular Aneurysm Repair.Sensors (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type II endoleak is the most common type of endoleak after endovascular repair of abdominal aortic aneurysm and has been reported in up to 20-50% of patients. Patients undergo lifelong surveillance of aortic graft stents to monitor for endoleak. Contrast-enhanced ultrasound can be an adjunct to CT angiography (CTA) which is the preferred imaging modality for surveillance. However, CT angiography introduces challenges of recurring cost, exposure to ionizing radiation, and the need for iodinated contrast dye. We report a case using CEUS for the detection of type II endoleak.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.